USD 0.01
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -348.16 Thousand | -513.68 Thousand | -272.19 Thousand | -5352.00 | -18.11 Thousand | -2.33 Million |
Net Income | -316.64 Thousand | -319.04 Thousand | -294.14 Thousand | -86.5 Thousand | 19.21 Thousand | -4.71 Million |
Depreciation & Amortization | - | - | - | - | - | 787.26 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | 172.05 Thousand | - | - | 504.02 Thousand |
Change in working capital | -35.44 Thousand | -201.02 Thousand | -143.87 Thousand | 114.99 Thousand | 356.02 Thousand | 262.58 Thousand |
Other non-cash items | 91.7 Thousand | 6380.00 | -6232.00 | -33.83 Thousand | -393.35 Thousand | 1.61 Million |
Investing Cash Flow | -28.4 Thousand | -104.89 Thousand | - | - | - | - |
Investments in PPE | -28.4 Thousand | -104.89 Thousand | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -28.4 Thousand | -104.89 Thousand | - | - | - | - |
Financing Cash Flow | - | 447.17 Thousand | 956.53 Thousand | 5176.00 | - | 2342.39 |
Debt repayment | - | -263.1 Thousand | -80.46 Thousand | -5176.00 | - | -86.82 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | -40 Thousand |
Common Stock Issuance | - | 710.28 Thousand | 812 Thousand | - | - | 2.29 Million |
Other Financing Activities | - | -263.1 Thousand | 144.53 Thousand | 5176.00 | - | 2342.39 |
Accounts receivables | -87.78 Thousand | -15.14 Thousand | 1060.00 | -173.00 | 50.33 Thousand | -50.76 Thousand |
Accounts payables | - | - | - | - | 300.64 Thousand | 311.37 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | 52.33 Thousand | -185.87 Thousand | -144.93 Thousand | 115.16 Thousand | 5053.00 | 1969.00 |
Cash at beginning of period | 513.31 Thousand | 684.71 Thousand | 383.00 | 559.00 | 18.67 Thousand | 9603.00 |
Cash at end of period | 136.75 Thousand | 513.31 Thousand | 684.71 Thousand | 383.00 | 559.00 | 18.67 Thousand |
Capital Expenditure | -28.4 Thousand | -104.89 Thousand | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -376.56 Thousand | -171.4 Thousand | 684.33 Thousand | -176.00 | -18.11 Thousand | 9074.00 |
Free Cash Flow | -376.56 Thousand | -618.57 Thousand | -272.19 Thousand | -5352.00 | -18.11 Thousand | -2.33 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -184.1 Thousand | -183.89 Thousand | -64.81 Thousand | -80.7 Thousand | -316.64 Thousand | -67.49 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 44.67 Thousand | - | 52.4 Thousand | - | - | - |
Change in working capital | 41.88 Thousand | 77.55 Thousand | -42.47 Thousand | -23.29 Thousand | -35.44 Thousand | 51.79 Thousand |
Other non-cash items | 31.69 Thousand | 5518.00 | 57 Thousand | 82.22 Thousand | 91.7 Thousand | 2600.00 |
Investing Cash Flow | -25 Thousand | -284.43 Thousand | - | 126.86 Thousand | -28.4 Thousand | -126.86 Thousand |
Investments in PPE | -25 Thousand | -284.43 Thousand | - | -28.4 Thousand | -28.4 Thousand | - |
Acquisitions | - | - | - | -8620.00 | - | 8620.00 |
Investment purchases | - | - | - | 28.4 Thousand | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -25 Thousand | - | - | 135.48 Thousand | - | -126.86 Thousand |
Financing Cash Flow | 33.81 Thousand | 493.35 Thousand | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 33.81 Thousand | 493.35 Thousand | - | - | - | - |
Other Financing Activities | -181.00 | 493.35 | - | - | - | - |
Accounts receivables | 10.61 Thousand | -7511.00 | -2491.00 | -78.29 Thousand | -87.78 Thousand | -2600.00 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 31.26 Thousand | 85.06 Thousand | -39.98 Thousand | 54.99 Thousand | 52.33 Thousand | 54.39 Thousand |
Cash at beginning of period | 184.54 Thousand | 83.96 Thousand | 136.75 Thousand | 109.96 Thousand | 513.31 Thousand | 252.52 Thousand |
Cash at end of period | 93.45 Thousand | 184.54 Thousand | 83.96 Thousand | 136.75 Thousand | 136.75 Thousand | 109.96 Thousand |
Capital Expenditure | -25 Thousand | -284.43 Thousand | - | -28.4 Thousand | -28.4 Thousand | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -91.09 Thousand | 100.58 Thousand | -52.78 Thousand | 26.78 Thousand | -376.56 Thousand | -142.56 Thousand |
Free Cash Flow | -124.91 Thousand | -392.76 Thousand | -52.78 Thousand | -128.47 Thousand | -376.56 Thousand | -15.69 Thousand |
STAR
2459
6456
WOCKPHARMA
ASBFY
PEB